6 research outputs found
A sustainable one-pot method to transform seashell waste calcium carbonate to osteoinductive hydroxyapatite micro-nanoparticles
We have developed a straightforward, one-pot, low-temperature hydrothermal method to transform oyster shell waste particles (bCCP) from the species Crassostrea gigas (Mg-calcite, 5 wt% Mg) into hydroxyapatite (HA) micro/nanoparticles. The influence of the P reagents (H3PO4, KH2PO4, and K2HPO4), P/bCCP molar ratios (0.24, 0.6, and 0.96), digestion temperatures (25-200 & DEG;C), and digestion times (1 week-2 months) on the transformation process was thoroughly investigated. At 1 week, the minimum temperature to yield the full transformation significantly reduced from 160 & DEG;C to 120 & DEG;C when using K2HPO4 instead of KH2PO4 at a P/bCCP ratio of 0.6, and even to 80 & DEG;C at a P/bCCP ratio of 0.96. The transformation took place via a dissolution-reprecipitation mechanism driven by the favorable balance between HA precipitation and bCCP dissolution, due to the lower solubility product of HA than that of calcite at any of the tested temperatures. Both the bCCP and the derived HA particles were cytocompatible for MG-63 human osteosarcoma cells and m17.ASC murine mesenchymal stem cells, and additionally, they promoted the osteogenic differentiation of m17.ASC, especially the HA particles. Because of their physicochemical features and biological compatibility, both particles could be useful osteoinductive platforms for translational applications in bone tissue engineering
Bioinspired Calcium Phosphate Coated Mica Sheets by Vapor Diffusion and Its Effects on Lysozyme Assembly and Crystallization
We
propose for the first time the vapor diffusion method to deposit
bioinspired calcium phosphate films on mineral substrates, that is,
delaminated mica muscovite sheets and to assess the capability of
these films to affect the nucleation and growth of lysozyme crystals.
Deposited calcium phosphate layers were composed of octacalcium phosphate
(OCP) and apatite (Ap) nanocrystals, with increased amount of OCP
at higher crystallization times. In the presence of polyĀ(acrylic acid)
(PAA) deposited layers were composed of amorphous calcium phosphate
(ACP). Results of lysozyme crystallization showed that OCP/Ap-coated
mica sheets slowed down the nucleation process without altering significantly
the number of nucleated crystals per droplet respect to the uncoated
control. ACP-coated mica sheets acted as an inhibitor, thus delaying
the nucleation and reducing in addition the number of crystals. These
results contrasted with the nucleation induction effect observed when
calcium phosphate nanopowders were added to the crystallization drops.
All coated-substrates promoted the formation of flat lysozyme crystals
at the substrateāsolution interface, and some of them retained
its laminar morphology. Unexpectedly, the ACP coatings templated the
2D assembly of lysozyme producing thin films. The observation of the
lysozyme thin films was possible only in those ACP-coated supports
prepared in the presence of 0.015 and 0.02 wt % PAA
Stearate-Coated Biogenic Calcium Carbonate from Waste Seashells: A Sustainable Plastic Filler
pH-Responsive Delivery of Doxorubicin from CitrateāApatite Nanocrystals with Tailored Carbonate Content
In
this work, the efficiency of bioinspired citrate-functionalized
nanocrystalline apatites as nanocarriers for delivery of doxorubicin
(DOXO) has been assessed. The nanoparticles were synthesized by thermal
decomplexing of metastable calcium/citrate/phosphate solutions both
in the absence (Ap) and in the presence (cAp) of carbonate ions. The
presence of citrate and carbonate ions in the solution allowed us
to tailor the size, shape, carbonate content, and surface chemistry
of the nanoparticles. The drug-loading efficiency of the two types
of apatite was evaluated by means of the adsorption isotherms, which
were found to fit a LangmuirāFreundlich behavior. A model describing
the interaction between apatite surface and DOXO is proposed from
adsorption isotherms and Ī¶-potential measurements. DOXO is adsorbed
as a dimer by means of a positively charged amino group that electrostatically
interacts with negatively charged surface groups of nanoparticles.
The drug-release profiles were explored at pHs 7.4 and 5.0, mimicking
the physiological pH in the blood circulation and the more acidic
pH in the endosome-lysosome intracellular compartment, respectively.
After 7 days at pH 7.4, cAp-DOXO released around 42% less drug than
Ap-DOXO. However, at acidic pH, both nanoassemblies released similar
amounts of DOXO. <i>In vitro</i> assays analyzed by confocal
microscopy showed that both drug-loaded apatites were internalized
within GTL-16 human carcinoma cells and could release DOXO, which
accumulated in the nucleus in short times and exerted cytotoxic activity
with the same efficiency. cAp are thus expected to be a more promising
nanocarrier for experiments <i>in vivo</i>, in situations
where intravenous injection of nanoparticles are required to reach
the targeted tumor, after circulating in the bloodstream
Transient Calcium Carbonate Hexahydrate (Ikaite) Nucleated and Stabilized in Confined Nano- and Picovolumes
Calcium carbonate precipitation at
different values of the nominal
ionic activity product (IAP) is studied in nanoliter and picoliter
droplets at (20 Ā± 2 Ā°C). Experiments are carried out through
direct mixing of equimolar reactant solutions using two different
setups: first, droplet-based microfluidics using Teflon capillaries
(nanoliter experiments) and second, the microinjection technique under
oil (picoliter droplets). Instantaneous precipitation of a metastable
CaCO<sub>3</sub> phase is initially observed. This phase is stabilized
in time by reducing the initial volume of the experiments from the
nano- to picoliters range and when the CaCl<sub>2</sub>/Na<sub>2</sub>CO<sub>3</sub> ratio approaches 1. Further analysis by X-ray diffraction,
transmission electron microscopy, and selected area electron diffraction
confirms the first nucleated phase is CaCO<sub>3</sub>Ā·6H<sub>2</sub>O (ikaite) and in few droplets ikaite plus CaCO<sub>3</sub>Ā·H<sub>2</sub>O (monohydrocalcite). No evidence of amorphous
calcium carbonate (ACC) is found even in conditions where the IAP
exceeds the solubility product of this phase. The in vitro finding
of ikaite formation and stabilization due to volume confinement is
an unexpected result since it is the first time that this hydrous
phase is stabilized at room temperature (it is normally found at near
0 Ā°C) in the absence of additives. This result can be of interest
for those biomineralization processes occurring in the confined volumes
of intracellular vesicles and for biomimetic materials science in
general